Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061. - Burkey BF; Hoglen NC; Inskeep P; Wyman M; Hughes TE; Vath JE (The Journal of pharmacology and experimental therapeutics, 2018)